MiR-502-5p inhibits IL-1β-induced chondrocyte injury by targeting TRAF2

Guoliang Zhang1, Yanhong Sun2, Yuewen Wang3

  • 1Orthopedical Center of Zhujiang Hospital, Southern Medical University, Guangzhou 510282, China; Department of Orthopedics, Affiliated Hospital of Inner Mongolia Medical University, Hohhot 010050, China.

Cellular Immunology
|February 11, 2016
PubMed

Insights

MicroRNA-502-5p is downregulated in osteoarthritis. Its overexpression protects chondrocytes from injury by targeting TRAF2 and inhibiting the NF-κB pathway, offering potential therapeutic benefits for osteoarthritis.

Area of Science:

  • Molecular Biology
  • Biochemistry
  • Cell Biology

Background:

  • Osteoarthritis (OA) involves articular cartilage degradation and joint inflammation.
  • MicroRNAs regulate chondrogenesis and are implicated in OA pathogenesis.

Purpose of the Study:

  • Investigate the role of miR-502-5p in osteoarthritis.
  • Determine the molecular mechanisms underlying miR-502-5p's function in chondrocytes.

Main Methods:

  • Quantitative analysis of miR-502-5p levels in OA tissues and chondrocytes.
  • Overexpression of miR-502-5p in IL-1β-induced chondrocyte injury model.
  • Assessment of cell viability, apoptosis, extracellular matrix (ECM) metabolism, and inflammatory cytokine production.
  • Target validation using 3'-untranslated region (UTR) assays and Western blotting.
  • Analysis of NF-κB signaling pathway activation.

Main Results:

  • miR-502-5p levels were significantly reduced in OA tissues and IL-1β-treated chondrocytes.
  • miR-502-5p overexpression enhanced chondrocyte viability, reduced apoptosis, and restored ECM balance.
  • miR-502-5p suppressed pro-inflammatory cytokine release.
  • miR-502-5p directly targeted TRAF2, inhibiting its expression.
  • miR-502-5p and TRAF2 siRNA transfection inhibited IL-1β-induced NF-κB activation.

Conclusions:

  • miR-502-5p demonstrates a protective role against IL-1β-induced chondrocyte injury.
  • The protective mechanism involves targeting TRAF2 and suppressing the NF-κB signaling pathway.
  • miR-502-5p represents a potential therapeutic target for osteoarthritis treatment.